• Featured Product
  • KD/KO Validated

PRKACA Monoclonal antibody, PBS Only

PRKACA Monoclonal Antibody for WB, IHC, ELISA

Cat No. 67491-1-PBS
Clone No.4G10D7

Host / Isotype

Mouse / IgG2a

Reactivity

human, mouse, rat, pig

Applications

WB, IHC, ELISA

4G10D7, cAMP-dependent protein kinase catalytic subunit alpha, EC:2.7.11.11, PKA C alpha, PKA C-alpha

Formulation:  PBS Only
Conjugate:  Unconjugated
Size/Concentration: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:


Product Information

67491-1-PBS targets PRKACA in WB, IHC, ELISA applications and shows reactivity with human, mouse, rat, pig samples.

Tested Reactivity human, mouse, rat, pig
Host / Isotype Mouse / IgG2a
Class Monoclonal
Type Antibody
Immunogen

CatNo: Ag26400

Product name: Recombinant human PRKACA protein

Source: e coli.-derived, PET28a

Tag: 6*His

Domain: 162-351 aa of BC039846

Sequence: DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIRVSINEKCGKEFSEF

Predict reactive species
Full Name protein kinase, cAMP-dependent, catalytic, alpha
Calculated Molecular Weight 41 kDa
Observed Molecular Weight 38-43 kDa
GenBank Accession NumberBC039846
Gene Symbol PRKACA
Gene ID (NCBI) 5566
RRIDAB_2882716
Conjugate Unconjugated
FormLiquid
Purification MethodProtein A purification
UNIPROT IDP17612
Storage Buffer PBS only, pH 7.3.
Storage ConditionsStore at -80°C.

Background Information

PRKACA (protein kinase cAMP-activated catalytic subunit alpha) is a gene that encodes the catalytic subunit alpha of protein kinase A (PKA), a critical enzyme in the cyclic adenosine monophosphate (cAMP) signaling pathway. Functioning as the primary effector of cAMP, this kinase regulates a vast array of cellular processes, including metabolism, gene expression, cell cycle progression, and synaptic plasticity. Under basal conditions, the catalytic subunit is held inactive by regulatory subunits; upon cAMP binding, it is released and phosphorylates a diverse range of substrate proteins on serine and threonine residues. Beyond its physiological roles, aberrant PRKACA activity, particularly gene fusions and copy number gains, is a well-established driver of specific human diseases, most notably fibrolamellar hepatocellular carcinoma (FLC), where a characteristic DNAJB1-PRKACA fusion acts as the oncogenic driver.

Loading...
||
New chat

Able

正在加载,请稍候...